ANI Pharmaceuticals (ANIP)
(Real Time Quote from BATS)
$60.11 USD
+3.91 (6.96%)
Updated Sep 17, 2024 01:55 PM ET
5-Strong Sell of 5 5
C Value C Growth C Momentum B VGM
ANI Pharmaceuticals (ANIP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$79.40 | $94.00 | $60.00 | 41.28% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for ANI Pharmaceuticals comes to $79.40. The forecasts range from a low of $60.00 to a high of $94.00. The average price target represents an increase of 41.28% from the last closing price of $56.20.
Analyst Price Targets (5 )
Broker Rating
ANI Pharmaceuticals currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 60% and 20% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.60 | 1.60 | 1.20 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/11/2024 | Truist Securities | Leszek Sulewski | Strong Buy | Hold |
9/11/2024 | Capital One Securities | Timothy Chiang | Strong Buy | Strong Buy |
6/26/2024 | H.C. Wainwright & Co. | Oren Livnat | Strong Buy | Strong Buy |
5/12/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
3/5/2024 | Guggenheim Securities | Vamil Divan | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.60 |
ABR (Last week) | 1.60 |
# of Recs in ABR | 5 |
Average Target Price | $79.40 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | 1.08 |
ANIP FAQs
ANI Pharmaceuticals, Inc. (ANIP) currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for ANI Pharmaceuticals, Inc. (ANIP) is $79.40. The current on short-term price targets is based on 3 reports.
The forecasts for ANI Pharmaceuticals, Inc. (ANIP) range from a low of $60 to a high of $94. The average price target represents a increase of $41.28 from the last closing price of $56.20.
The current UPSIDE for ANI Pharmaceuticals, Inc. (ANIP) is 41.28%
Based on short-term price targets offered by five analysts, the average price target for ANI Pharmaceuticals comes to $79.40. The forecasts range from a low of $60.00 to a high of $94.00. The average price target represents an increase of 41.28% from the last closing price of $56.20.